SEC Form 4 · accession 0001649989-26-000008
Outlook Therapeutics, Inc. · OTLK
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Faisal Ghiath Sukhtian
Director
Period of report
Jul 29, 2026
Accepted (ET)
Jul 29, 2026 · 3:19 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001649989
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jul 29, 2026 | P | 95,398 | $1.0482 | A | 220,972 | D |
Table II — derivative securities
No Table II lines on this filing.